Chrome Extension
WeChat Mini Program
Use on ChatGLM

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma

JOURNAL OF CLINICAL ONCOLOGY(2024)

Cited 0|Views1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined